Testbiotech: The publicly funded research institution should take on a role model function
Tuesday, 3 May 2016
Testbiotech has filed an opposition against Patent EP2328918 issued to the Max Planck Society, based in Munich. This patent claims genetically engineered animals, even including primates as “inventions”. Testbiotech believes the patent constitutes an unacceptable violation of ethical boundaries. In a letter to the president of the Max Planck Society, Testbiotech is now arguing that the publicly funded German research institution should take a leading role in protecting the interests of civil society, and initiate changes to the patent of its own accord.
2 May 2016 / A newly published report shows that the introduction of the free trade agreements between EU and Canada (CETA) and the US (TTIP) will almost certainly lead to lower EU standards in protection of consumers and the environment. Contrary to some public statements that have been made, both the German government and the EU Commission are aware of these consequences. The report written by Christoph Then was published by Greenpeace Germany.
EFSA and Monsanto are ignoring risks for farmers and the environment
Friday, 22 April 2016
In an open letter to the EU Commission, several Spanish, British and German organisations are urging that effective measures be taken to prevent genetically engineered maize from spreading into the environment. As evidenced by the organisations, the ancestor of cultivated maize, teosinte, is widely invading agricultural landscapes in several regions of Spain where, in some cases, the genetically engineered maize MON810 is also cultivated which is producing an insecticidal protein.
EU Commission intends to have a much stricter regulatory approach than the US
21 April 2016 / Greenpeace, Gene Watch UK and Corporate Europe Observatory (CEO) today published internal European Commission documents on TTIP and new genetic engineering methods such as CRISPR / Cas. They show that the United States is exerting enormous pressure in a bid to stop plants engineered with new genome editing technologies from being subject to EU genetic engineering regulation. According to industry and the US government, these plants should be commercialised without having to undergo the authorisation process.
English
Deutsch
